Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-007-1 | CAS number: 1719-58-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 26.5 mg/m³
DNEL related information
- DNEL derivation method:
- other: based on 8-hour IOEL for HCl
- Dose descriptor:
- other: EU IOEL
Acute/short term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 49.6 mg/m³
DNEL related information
- DNEL derivation method:
- other: based on 15-min STEL for HCl
- Dose descriptor starting point:
- other: EU OEL
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- high hazard (no threshold derived)
Additional information - workers
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
The following discussion justifies the use of the conclusion 'no hazard identified' for humans exposed via the environment. Oral exposure is only relevant for the assessment of exposure via the environment as there are no consumer uses of this substance.
Background
Due to the very rapid hydrolysis of chloro(dimethyl)vinylsilane, relevant environmental exposure would not be to the parent substance but to the hydrolysis products, dimethyl(vinyl)silanol and HCl. At environmentally-relevant concentrations, the silicon-containing hydrolysis product would be present predominantly as monomeric silanol.
In general, the assessment of the potential level of human risk via the environment is done by first calculating a Derived-No-Effect-Level (DNEL) for the General Population for the relevant route(s) e.g. oral and in some cases, inhalation.
The route of choice for studies most relevant to exposure via the environment is the oral route, since direct exposure to the general population to chlorosilanes or silanols via air emissions from industrial sites is negligible.
Toxicity data for the silicon-containing hydrolysis product are read across from the related substance trimethylsilanol. However, the doses and concentrations used in the toxicity studies are not relevant for the environmental exposure assessment. This is because silanols undergo condensation reactions at the high concentrations that can occur internally in test animals. This means that what the animals are actually exposed to in toxicity studies is not only the monomer, which would be present in the environment, but the dimer (assuming that the behaviour in the GI tract follows the in vitro chemical behaviour). Therefore any observed effects could be due to exposure to the dimer and would then not be relevant for exposure via the environment, where low concentrations mean that condensation is not significant.
A toxicity study conducted at doses and concentrations low enough to ensure exposure to monomer only, i.e. minimal condensation reactions occurring, would almost certainly not result in any systemic toxicological effects.
Discussion
Chloro(dimethyl)vinylsilane undergoes condensation reactions in solution to give siloxane dimers (1,1,3,3 -tetramethyl-1,3 -divinyldisiloxane, CAS 2627 -95 -4). A dynamic equilibrium is established and under certain conditions an insoluble product is formed. The overall rate and extent of condensation is dependent on nominal loading, temperature, and pH of the system, as well as what else is present in the solution. The condensation reactions of monosilanols may be modelled as an equilibrium between monomer and dimer. The reactions are reversible unless the dimer concentration exceeds its solubility; in this case, the dimer forms a separate phase, driving the equilibrium towards the dimer. For dimethyl(vinyl)silanol, an aqueous solution at 100 mg/l is predicted to contain >99% monomer, with very small amounts of dimer. At loadings above about 250 mg/l the concentration of the dimer of the silanol hydrolysis product is predicted to exceed its solubility, resulting in formation of a separate phase.
Following dosing by oral gavage, partitioning will occur between the dose vehicle and the aqueous environment in the stomach.
Mass dosed = Body weight (in kg) x dose level (in mg/kg bw day)
Dose Concentration = mass dosed/volume
This represents an upper limit of the concentration as some of the substance is expected to adsorb to fatty tissue or remain dissolved in the dose vehicle (until this is broken down).
For a study conducted at a dose level of 10 mg/kg bw/day and assuming a body weight of 300 g, the total amount dosed is therefore 3 mg, into an estimated aqueous volume of 1.5 ml in the rat stomach. The concentration in water is therefore up to 2000 mg/l. At such a concentration, condensation is already an important factor.
Body weight = 300 g = 0.3 kg
Total amount dosed = 3 mg
Estimated aqueous volume = 1.5 ml
Dose concentration = 2000 mg/l
At a typical upper dose level of 1000 mg/kg bw/day the corresponding concentration would be up to 200 000 mg/l.
Body weight = 300 g = 0.3 kg
Total amount dosed = 300 mg
Estimated aqueous volume = 1.5 ml
Dose concentration = 200 000 mg/l
Based on a condensation limit of 250 mg/l, the maximum dose level that could be used in practice to ensure exposure mainly to monomeric [dimethyl(vinyl)silanol] is approximately 1.25 mg/kg bw/day or less.
Body weight = 300 g = 0.3 kg
Total amount dosed = 0.375 mg
Estimated aqueous volume = 1.5 ml
Dose concentration = 250 mg/l
Therefore, any in vivo study relevant to MvE would have to be conducted at doses that would not result in any useful toxicological information and as such would not be ethical to conduct from an animal usage perspective. This ethical point has been confirmed by third parties in the recent consultations required for the trichlorosilane legal action (Case No. A-017 -2015).
Conclusion
In conclusion, it can be demonstrated that testing for the assessment of chloro(dimethyl)vinylsilane via the environment is neither ethical nor technically feasible. In REACH terms it can therefore be concluded that there is no hazard identified for humans via the environment.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.